Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Treasury Shares (2023 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Treasury Shares for 3 consecutive years, with $180000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $180000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $180000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $180000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares hit $2.1 million in Q4 2025 for Connect Biopharma Holdings, down from $2.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.5 million in Q4 2024 to a low of $2.1 million in Q4 2025.
  • Historically, Treasury Shares has averaged $2.4 million across 3 years, with a median of $2.4 million in 2023.
  • Biggest YoY gain for Treasury Shares was 0.0% in 2024; the steepest drop was 0.0% in 2024.
  • Year by year, Treasury Shares stood at $180000.0 in 2023, then changed by 0.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025.
  • Business Quant data shows Treasury Shares for CNTB at $180000.0 in Q4 2025, $180000.0 in Q3 2025, and $180000.0 in Q2 2025.